✦ LIBER ✦

Assessing the costs for clinical care of patients with high-responding factor VIII and IX inhibitors

✍ Scribed by M. ULLMAN; W. K. HOOTS

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of factor VIII infusions i

✍ S. Kasuda; I. Tanaka; M. Shima; T. Matsumoto; Y. Sakurai; K. Nishiya; A. R. Gile 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Low-dose activated factor IX complex con

✍ A. BHAVE; A. SRIVASTAVA; V. LEE; A. J. DANIEL; D. DENNISON; G. D. SUNDERAJ; A. S 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

An open clinical study assessing the eff

✍ T. LISSITCHKOV; M. MATYSIAK; K. ZAWILSKA; L. GERCHEVA; A. ANTONOV; M. MONTAÑES; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

The use of recombinant factor VIIa (rVII

📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 448 KB

Factor VIII gene (F8) mutations as predi

✍ A. COPPOLA; M. MARGAGLIONE; E. SANTAGOSTINO; A. ROCINO; E. GRANDONE; P. M. MANNU 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Unresponsiveness to factor VIII inhibito

✍ T. Hayashi; I. Tanaka; M. Shima; K. Yoshida; K. Fukuda; Y. Sakurai; T. Matsumoto 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB